M. Gutiérrez-Hernandez

Pathophysiology of perinatal asphyxia: can we predict and improve individual outcomes?

P. Morales, M. Gutiérrez-Hernández, D. Bustamante, 2011, EPMA Journal.

Perinatal asphyxia: CNS development and deficits with delayed onset

P. Gebicke-haerter, P. Morales, M. Herrera-Marschitz, 2013, Front. Neurosci..

Further Studies on the Hypothesis of PARP-1 Inhibition as a Strategy for Lessening the Long-Term Effects Produced by Perinatal Asphyxia: Effects of Nicotinamide and Theophylline on PARP-1 Activity in Brain and Peripheral Tissue

P. Gebicke-haerter, P. Morales, M. Herrera-Marschitz, 2012, Neurotoxicity Research.

Perinatal asphyxia: current status and approaches towards neuroprotective strategies, with focus on sentinel proteins

P. Gebicke-haerter, M. Morelli, P. Morales, 2010, Neurotoxicity Research.

Functional Selectivity of Hallucinogenic Phenethylamine and Phenylisopropylamine Derivatives at Human 5-Hydroxytryptamine (5-HT)2A and 5-HT2C Receptors

P. Moya, M. Reyes-Parada, B. Cassels, 2007, Journal of Pharmacology and Experimental Therapeutics.

Crystal structure of (1r,5s)-9-nitro-1,2,3,4,5,6-hexahydro-1,5-methanopyrido[1,2-a][1,5] diazocin-8-one (9-nitrocytisine), c11h13o3n3

B. Cassels, A. Galdámez, P. Sáez-Briones, 2011 .

Perinatal Asphyxia Leads to PARP-1 Overactivity, p65 Translocation, IL-1β and TNF-α Overexpression, and Apoptotic-Like Cell Death in Mesencephalon of Neonatal Rats: Prevention by Systemic Neonatal Nicotinamide Administration

P. Gebicke-haerter, P. Morales, M. Herrera-Marschitz, 2015, Neurotoxicity Research.

Perinatal asphyxia: CNS development and deficits with delayed onset

P. Gebicke-haerter, P. Morales, M. Herrera-Marschitz, 2013, Front. Neurosci..